JP2007516206A5 - - Google Patents

Download PDF

Info

Publication number
JP2007516206A5
JP2007516206A5 JP2006518669A JP2006518669A JP2007516206A5 JP 2007516206 A5 JP2007516206 A5 JP 2007516206A5 JP 2006518669 A JP2006518669 A JP 2006518669A JP 2006518669 A JP2006518669 A JP 2006518669A JP 2007516206 A5 JP2007516206 A5 JP 2007516206A5
Authority
JP
Japan
Prior art keywords
aryl
alkyl
heteroaryl
compound
conr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006518669A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007516206A (ja
Filing date
Publication date
Priority claimed from US10/874,743 external-priority patent/US7122548B2/en
Application filed filed Critical
Publication of JP2007516206A publication Critical patent/JP2007516206A/ja
Publication of JP2007516206A5 publication Critical patent/JP2007516206A5/ja
Withdrawn legal-status Critical Current

Links

JP2006518669A 2003-07-02 2004-06-25 トリアゾロトリアジン化合物およびそれらの使用 Withdrawn JP2007516206A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48422103P 2003-07-02 2003-07-02
US10/874,743 US7122548B2 (en) 2003-07-02 2004-06-24 Triazolotriazine compounds and uses thereof
PCT/US2004/020054 WO2005010005A1 (en) 2003-07-02 2004-06-25 Triazolotriazine compounds and uses thereof

Publications (2)

Publication Number Publication Date
JP2007516206A JP2007516206A (ja) 2007-06-21
JP2007516206A5 true JP2007516206A5 (https=) 2007-08-09

Family

ID=34107700

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006518669A Withdrawn JP2007516206A (ja) 2003-07-02 2004-06-25 トリアゾロトリアジン化合物およびそれらの使用

Country Status (5)

Country Link
US (1) US7122548B2 (https=)
EP (1) EP1644377A4 (https=)
JP (1) JP2007516206A (https=)
CA (1) CA2529238A1 (https=)
WO (1) WO2005010005A1 (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550470B2 (en) * 2002-12-11 2009-06-23 Merck & Co. Inc. Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors
CN101198590B (zh) 2005-08-24 2012-05-09 卫材R&D管理有限公司 吡啶衍生物及嘧啶衍生物（3）
CN101360748B (zh) * 2005-11-30 2012-05-30 沃泰克斯药物股份有限公司 c-MET抑制剂及其应用
RU2419620C2 (ru) * 2005-11-30 2011-05-27 Вертекс Фармасьютикалз Инкорпорейтед Ингибиторы с-мет и их применение
KR20080080584A (ko) * 2005-11-30 2008-09-04 버텍스 파마슈티칼스 인코포레이티드 ｃ-Ｍｅｔ의 억제제 및 이의 용도
HRP20170103T1 (hr) 2005-12-21 2017-03-24 Janssen Pharmaceutica N.V. Triazolopiridazini kao modulatori tirozin kinaze
WO2007103308A2 (en) 2006-03-07 2007-09-13 Array Biopharma Inc. Heterobicyclic pyrazole compounds and methods of use
JP2009539878A (ja) * 2006-06-08 2009-11-19 アレイ バイオファーマ、インコーポレイテッド キノリン化合物および使用方法
US8198448B2 (en) 2006-07-14 2012-06-12 Amgen Inc. Fused heterocyclic derivatives and methods of use
PE20080403A1 (es) 2006-07-14 2008-04-25 Amgen Inc Derivados heterociclicos fusionados y metodos de uso
US8217177B2 (en) 2006-07-14 2012-07-10 Amgen Inc. Fused heterocyclic derivatives and methods of use
EP2057164A1 (en) * 2006-08-07 2009-05-13 Incyte Corporation Triazolotriazines as kinase inhibitors
CA2661333C (en) 2006-08-23 2014-08-05 Eisai R&D Management Co., Ltd. Salt of phenoxypyridine derivative or crystal thereof and process for producing the same
US7790885B2 (en) 2006-08-31 2010-09-07 Eisai R&D Management Co., Ltd. Process for preparing phenoxypyridine derivatives
WO2008030744A2 (en) * 2006-09-05 2008-03-13 Board Of Regents, The University Of Texas System Inhibitors of c-met and uses thereof
JP2010519174A (ja) * 2006-09-18 2010-06-03 バーテックス ファーマシューティカルズ インコーポレイテッド ｃ−Ｍｅｔの複素環阻害薬およびその使用方法
ES2555803T3 (es) 2006-10-23 2016-01-08 Cephalon, Inc. Fusión de derivados bicíclicos 2,4-diaminopirimidina como utilizar inhibidores ALK y c-Met
BRPI0717320A2 (pt) * 2006-10-23 2013-10-22 Sgx Pharmaceuticals Inc Triazóis bicíclicos como moduladores de proteína cinase
RS54510B1 (sr) * 2006-11-22 2016-06-30 Incyte Holdings Corporation Imidazotriazini i imidazopirimidini kao inhibitori kinaze
WO2008079294A1 (en) * 2006-12-20 2008-07-03 Amgen Inc. Substituted heterocycles and methods of use
AU2007338792B2 (en) 2006-12-20 2012-05-31 Amgen Inc. Substituted heterocycles and methods of use
US8066118B1 (en) 2006-12-25 2011-11-29 Marty Van Tassell Device for using nonwoven towels in the dairy industry
EP2170894A1 (en) * 2007-06-21 2010-04-07 Janssen Pharmaceutica N.V. Polymorphic and hydrate forms, salts and process for preparing 6-{difluoro[6-(1-methyl-1h-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline
JP2009132660A (ja) 2007-11-30 2009-06-18 Eisai R & D Management Co Ltd 食道癌治療用組成物
UY31676A1 (es) 2008-02-28 2009-09-30 "derivados de 3-metil-imidiazo-[1,2-b]-piridazina"
TWI472529B (zh) 2008-05-21 2015-02-11 Incyte Corp ２－氟－Ｎ－甲基－４－〔７－（喹啉－６－基－甲基）－咪唑并〔１，２－ｂ〕〔１，２，４〕三－２－基〕苯甲醯胺之鹽類及其相關製備方法
CA2724715A1 (en) 2008-05-22 2009-11-26 Amgen Inc. Heterocycles as protein kinase inhibitors
CN102137939A (zh) * 2008-08-29 2011-07-27 霍夫曼-拉罗奇有限公司 不依赖vegf的肿瘤的诊断和治疗
JP2012504606A (ja) * 2008-10-01 2012-02-23 ラディック インスティテュート フォー キャンサー リサーチ 癌の治療方法
US8592448B2 (en) 2008-11-20 2013-11-26 OSI Pharmaceuticals, LLC Substituted pyrrolo[2,3-b]-pyridines and -pyrazines
NZ596616A (en) * 2009-05-28 2013-05-31 Vertex Pharma Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase
US8389526B2 (en) 2009-08-07 2013-03-05 Novartis Ag 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
EA201200260A1 (ru) 2009-08-12 2012-09-28 Новартис Аг Гетероциклические гидразоны и их применение для лечения рака и воспаления
CA2771432A1 (en) 2009-08-20 2011-02-24 Novartis Ag Heterocyclic oxime compounds
EA030141B1 (ru) 2009-12-31 2018-06-29 Хатчисон Медифарма Лимитед Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения
MX2012008898A (es) 2010-02-03 2012-11-06 Incyte Corp Imidazo - [1, 2 - b] [1, 2, 4] triazinas como inhibidores de c - met.
AR081039A1 (es) 2010-05-14 2012-05-30 Osi Pharmaceuticals Llc Inhibidores biciclicos fusionados de quinasa
EP2569315A1 (en) 2010-05-14 2013-03-20 OSI Pharmaceuticals, LLC Fused bicyclic kinase inhibitors
CN102532141A (zh) 2010-12-08 2012-07-04 中国科学院上海药物研究所 [1，2，4]三唑并[4，3-b][1，2，4]三嗪类化合物、其制备方法和用途
JP2014513724A (ja) 2011-05-16 2014-06-05 オーエスアイ・ファーマシューティカルズ，エルエルシー 融合二環キナーゼ阻害剤
WO2013152252A1 (en) 2012-04-06 2013-10-10 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
RU2016141385A (ru) 2014-03-24 2018-04-28 Дженентек, Инк. Лечение рака антагонистами с-мет и их корреляция с экспрессией hgf
WO2020103939A1 (zh) * 2018-11-22 2020-05-28 上海科技大学 三唑并环类化合物、其制备方法、中间体和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042471A (en) 1963-01-16 1966-09-14 Ilford Ltd Penta-azaindenes, their production and use in photographic emulsions
FR1379480A (fr) 1963-01-16 1964-11-20 Ilford Ltd Nouveaux penta-aza-indènes, préparation et utilisation de ces composés
GB1028809A (en) 1964-01-21 1966-05-11 Ferrania Spa Process for stabilizing photographic emulsions
US4405619A (en) 1981-09-02 1983-09-20 Diamond Shamrock Corporation Antiinflammatory substituted-1,2,4-triazolo[4,3-b]-1,2,4-triazines
IT1269176B (it) 1994-01-11 1997-03-21 Isagro Srl Eterobicicli ad attivita' fungicida

Similar Documents

Publication Publication Date Title
JP2007516206A5 (https=)
RU2323934C2 (ru) Индольные, азаиндольные и родственные гетероциклические 4-алкенилпиперидинамиды
JP2009526830A5 (https=)
JP2006515858A5 (https=)
JP2007534695A5 (https=)
JP2005501120A5 (https=)
JP2004528334A5 (https=)
JP2009263394A5 (https=)
JP2008535903A5 (https=)
JP2011513305A5 (https=)
BRPI0411365A (pt) derivados de aminopiridina
JP2002543183A5 (https=)
JP2007501831A5 (https=)
JP2010526814A5 (https=)
JP2013510178A5 (https=)
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
TW200502230A (en) Dual nk1/nk3 derivatives
JP2010501478A5 (https=)
NO20071234L (no) Forbindelser som potensierer glutamatreseptor og anvendelse derav innen medisin
JP2012512863A5 (https=)
JP2005537323A5 (https=)
JP2005518357A5 (https=)
JP2022500383A5 (https=)
CA2617991A1 (en) N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
JP2013544854A5 (https=)